Endoscopic full-thickness resection using an over-the-scope device for treatment of recurrent / residual colorectal neoplasia: a single-center case series
BMC Gastroenterology volume 19, Article number: 121 (2019)
Endoscopic mucosal resection (EMR) in piecemeal technique is the treatment standard for larger flat or sessile colorectal lesions. The method is burdened by a high recurrence rate mostly presenting as difficult to resect lesions. In these situations, endoscopic full thickness resection (EFTR) with an over-the-scope device offers the option of complete resection despite scar formation.
We conducted a retrospective case review of 30 consecutive EFTR interventions on small (< 20 mm), difficult to resect recurrent / residual colorectal neoplastic lesions treated by EFTR.
EFTR was technically feasible in 28/30 (93,3%) of the cases with an R0 resection in 24/30 (80%) and a median procedure time (marking to full thickness resection) of 34,5 min (11–120). After the first 15 procedures, the per-protocol rate increased from 13/15 to 15/15 and the R0 resection rate increased from 9/15 (69,2%) to 15/15 (100,0%; p < 0.01). One patient suffered from a delayed perforation the day after the procedure and needed emergency surgery (3,6%). Minor bleeding occurred in 3/28 patients (10,7%) and post-interventional fever in one patient (3,6%). The 30-day mortality rate was 0%.
EFTR with an over-the-scope device is a useful method for endoscopic resection of difficult to treat recurrent or residual colorectal neoplasia after previous endoscopic therapy. High R0 resection rates were observed after a relatively short learning curve. The complication rate in this series seems acceptable given the complexity of the resected lesions.
Polypectomy and endoscopic mucosal resection (EMR) - either en bloc or in piecemeal fashion – are established treatment standards for colorectal neoplasia such as adenoma or low risk early cancer [1,2,3]. Problems arise in cases of incomplete resections after fragmented (so called ‘piecemeal’) mucosectomy with reported recurrence rates of 20–30% [4, 5]. In fact, incomplete polypectomy probably has a relevant impact on interval cancers . While recurrences after previous endoscopic therapy are usually small, their treatment is difficult due to scar formation. Even endoscopic submucosal dissection (ESD) - favored by Japanese guidelines  - does not reliably result in R0 resections in cases of severe fibrosis [8, 9].
Recently, an endoscopic full-thickness resection (EFTR) device (FTRD®, Ovesco, Germany) has been developed. The device combines a large over-the-scope-clip (OTSC) to create a full thickness plication with a snare, which is subsequently used to cut the full thickness specimen [10, 11]. The method has been applied for the treatment of colorectal non-lifting lesions, lesions in anatomically difficult localization and also for smaller subepithelial tumors in several case series and one large prospective multicenter study [12,13,14,15,16,17,18,19]. In this study, we have focused on the clinically important aspect of endoscopic treatment for difficult to resect colorectal neoplasia after previous endoscopic therapy.
Patients and lesions
Between 01/2016 and 11/2018 we performed 30 endoscopic full thickness resections using the FTRD® device (Ovesco, Tübingen, Germany) in 29 consecutive patients (19 male / 10 female; median age 72,7 years / range 21,5-81,6; Table 1). All lesions were < 20 mm in size and were judged difficult to resect because of non-lifting due to scar formation after previous endoscopic resection. Localization of the lesions was in the right colon (n = 18), left colon (n = 9) and rectum (n = 3). The procedure time was measured from the initial marking of the lesion until the final endoscopic control of the clip closure. All procedures were performed by a single endoscopist (F.L.D.) who had received team training with the FTRD® device on isolated pig colon provided by the manufacturer. Informed consent for the procedure was obtained from all patients. Data on endoscopic procedures were prospectively recorded (Clinic WinData, E&L, Erlangen, Germany). Retrospective analysis was done by review of the digital patient charts. The study conforms to the provisions of the Declaration of Helsinki. It was approved by institutional board review of the Gemeinschaftskrankenhaus Bonn and - in accordance with federal regulations (§ 15 of the professional code / ‘Berufsordnung für die nordrheinischen Ärztinnen und Ärzte’) - specific consent to participate in this retrospective case series was waived.
EFTR procedure with the FTRD device
EFTR was carried out under conscious sedation with propofol, fentanyl and prophylactic single shot antibiosis (cefuroxime). After endoscopic evaluation and marking of the lesion (Fig. 1a, b), the FTRD® system was mounted and the endoscope re-advanced to the lesion. Full thickness resection with the integrated snare was accomplished after pulling the tissue into the cap and release of the clip (Fig. 1c, d). The settings of the Erbe Vio 3 electrosurgical unit (Erbe Elektromedizin, Tübingen, Germany) were forced coagulation 1.0 for initial marking of the target lesion and endocut Q 1.0 for cutting the lesion. After retrieval of the specimen and removal of the FTRD® system a repeat endoscopy was performed to control the positioning of the clip (Fig. 1e) and to rule out any possible injury that might have happened during the passage of the FTRD® device to the target lesion.
The specimens were gently stretched and then fixed on corkboard. Histopathology was performed with specific attention to the resection margins to confirm a complete resection (Fig. 1f). Patients with early cancer were presented in the interdisciplinary tumor board.
Patients had a liquid diet for the first 6 h after the procedure and were allowed to consume a soft diet the day after. We performed clinical visits and laboratory controls on the evening after the procedure as well as on the first post-interventional days and in any case of suspected adverse events. The majority of patients could be discharged on the second post-interventional day. We recommended follow up endoscopies in accordance with the current German S3 guideline .
Definition of outcome and complications
We defined ‘technical feasibility’ as reaching the target lesion and ‘R0 resection’ if both vertical and lateral margins were free of adenoma or cancer. A ‘perforation’ was diagnosed if a complete transmural lesion was identified during the procedure or if clinical and radiological signs of perforation were demonstrated after the procedure. A ‘major bleeding’ was defined as a loss of ≥3 hemoglobin units with signs of gastrointestinal bleeding after the completion of the intervention.
Group comparisons were done with Fisher’s exact test for categorical (https://www.socscistatistics.com) and students t-test (Microsoft Excel for Mac 2011) for continuous variables.
EFTR was technically feasible in 28/30 patients (93,3%) with a median procedure time (marking to full thickness resection) of 34,5 min (range 11–120). In two patients the FTRD device could not be advanced to the lesion due to sigmoid (inflammatory) strictures. Both full thickness and R0 resection rates were of 80% (24/30) on intent to treat analysis and 85,7% (24/28) on per protocol analysis (Fig. 2, Table 2).
In four EFTR interventions we could not achieve R0 resection. The endoscopic resection was judged complete in two of them, but histology showed positive resection margins. Follow up has been done for one patient and did not show residual neoplasia. In two other patients we had experienced difficulties in mobilizing the colonic wall into the resection cap due to fibrosis. The resection was diagnosed as incomplete at the final endoscopic control of the resection area. One patient had additional surgery due to high grade intraepithelial neoplasia; follow up data are not available for the other (Fig. 2).
The final histology showed advanced lesions in 12 patients including four carcinomas that had been diagnosed beforehand for possible curative treatment (Table 3). Two of these were evaluated as low risk lesions and - according to the German S3 guideline  – the patients were left without additional surgery. The two other lesions had been classified as potentially deep submucosal invasive according to the NICE classification  and the patients had been informed about the possibility of a non-curative resection. Histopathology showed pT2, G2, Pn0, L0, V0 - R0 in both cases and surgery was recommended. No lymph node metastasis was found after surgical resection in one patient; the other refused additional treatment and is without recurrence or metastasis after 14 months of follow-up.
Endoscopic follow-up data are available for 12 patients with one adenoma recurrence despite previous R0 EFTR resection after intial piecemeal EMR of a large rectal lesion (Fig. 2).
We observed one major complication, a delayed perforation the day after EFTR necessitating emergency surgery. In addition, three patients reported minor, self-limiting hematochezia and one patient developed fever without abdominal pain after EFTR. The 30-day mortality rate was 0% (Table 2).
When analyzing the efficacy and complication rates of EFTR procedures a significant increase in R0 resection rate was observed after the first 15 procedures (9/15 vs. 15/15; p < 0.01). Procedure times were not significantly decreased: median 36 min (range 21–120) versus 31 min (range 11–69). Of note, the two cases where the FTRD device could not be advanced to the lesion were among the first 15 procedures.
To date, there are limited data on endoscopic full thickness resection with the FTRD device including one large prospective study treating both epithelial and subepithelial lesions [15,16,17,18,19]. While these studies mainly concentrated on technical aspects, including EFTR for different indications, this study focused on EFTR procedures with the FTRD device in patients with difficult to treat, non-lifting residual / recurrent neoplasia after previous endoscopic resection. Indeed, this is a very common problem, giving the fact that fractionated mucosectomy is the standard treatment for larger flat or sessile colorectal neoplasia in western countries. We observed two treatment failures, were the device could not be advanced to the target lesion. For the remaining 28 procedures the R0 resection rate was 85,7%. A relatively quick learning curve was observed for the R0 resection rate, which increased from 9/15 to 15/15. Emergency surgery was needed in one patient when perforation developed the day after the procedure.
The efficacy data presented here are comparable to data from the largest prospective study with the FTRD device published  and two other smaller case series [16, 17, 19] (Table 4). They are also comparable to results of ESD in these particular situations . However, compared to other advanced endoscopic resection techniques such as ESD , the method has a quick learning curve, which lead to an R0 resection of 100% after having performed the first 15 cases.
The specific advantage of full thickness resection became obvious in the case of the two high-risk cancers. In fact, these lesions were already pT2 cancers with initial infiltration of the proper muscle layer. In this situation EMR or ESD might have resulted in perforation and potential translocation of cancerous tissue – which was avoided by full thickness R0 resection. On the other hand it must be emphasized, that even R0 resection of a recurrence does not rule out further recurrence at the same resection site. Thus, one patient developed a second recurrence despite initial R0 resection of a first recurrence. It is therefore mandatory to encourage timely endoscopic follow up – even after R0 resection of a recurrent adenoma – in particular if recurrence occurs after fragmented resection of a very large adenoma.
The rate of emergency surgery reported here is relatively high compared to other EFTR studies [14,15,16, 18] or to studies on EMR or ESD [1, 3, 7]. We think this is due to the fact that the study included only a relatively small number of cases. Moreover, no perforation occurred after the first 15 interventions. Finally, it must be pointed out, that EFTR was performed on lesions that otherwise would have been treated either by coagulation (i.e. no control over completeness of eradication) or sent for laparoscopic surgery.
In conclusion, EFTR with the FTRD device is a useful tool for smaller sized difficult-to-resect colorectal neoplasia e.g. after previous piecemeal resection. After a short learning curve high R0 resection rates are observed. The rate of emergency surgery is substantial but seems acceptable given the complexity of the resected lesions.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Endoscopic full thickness resection
Endoscopic mucosal resection
Endoscopic submucosal dissection
Full thickness resection device
Ferlitsch M, Moss A, Hassan C, Bhandari P, Dumonceau JM, Paspatis G, et al. Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2017;49(3):270–97.
Hwang JH, Konda V, Abu Dayyeh BK, Chauhan SS, Enestvedt BK, Fujii-Lau LL, et al. Endoscopic mucosal resection. Gastrointest Endosc. 2015;82(2):215–26.
Schmiegel W, Buchberger B, Follmann M, Graeven U, Heinemann V, Langer T, et al. S3-Leitlinie – Kolorektales Karzinom. Zeitschrift fur Gastroenterologie. 2017;55(12):1344–498.
Belderbos TD, Leenders M, Moons LM, Siersema PD. Local recurrence after endoscopic mucosal resection of nonpedunculated colorectal lesions: systematic review and meta-analysis. Endoscopy. 2014;46(5):388–402.
Knabe M, Pohl J, Gerges C, Ell C, Neuhaus H, Schumacher B. Standardized long-term follow-up after endoscopic resection of large, nonpedunculated colorectal lesions: a prospective two-center study. Am J Gastroenterol. 2014;109(2):183–9.
Robertson DJ, Lieberman DA, Winawer SJ, Ahnen DJ, Baron JA, Schatzkin A, et al. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2014;63(6):949–56.
Tanaka S, Kashida H, Saito Y, Yahagi N, Yamano H, Saito S, et al. JGES guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection. Dig Endosc. 2015;27(4):417–34.
Hong SN, Byeon JS, Lee BI, Yang DH, Kim J, Cho KB, et al. Prediction model and risk score for perforation in patients undergoing colorectal endoscopic submucosal dissection. Gastrointest Endosc. 2016;84(1):98–108.
Sato K, Ito S, Kitagawa T, Kato M, Tominaga K, Suzuki T, et al. Factors affecting the technical difficulty and clinical outcome of endoscopic submucosal dissection for colorectal tumors. Surg Endosc. 2014;28(10):2959–65.
Schurr MO, Buess G, Raestrup H, Arezzo A, Buerkert A, Schell C, et al. Full thickness resection device (FTRD) for endoluminal removal of large bowel tumours: development of the instrument and related experimental studies. Minim Invasive Ther Allied Technol. 2001;10(6):301–9.
Schurr MO, Baur FE, Krautwald M, Fehlker M, Wehrmann M, Gottwald T, et al. Endoscopic full-thickness resection and clip defect closure in the colon with the new FTRD system: experimental study. Surg Endosc. 2015;29(8):2434–41.
Sarker S, Gutierrez JP, Council L, Brazelton JD, Kyanam Kabir Baig KR, Monkemuller K. Over-the-scope clip-assisted method for resection of full-thickness submucosal lesions of the gastrointestinal tract. Endoscopy. 2014;46(9):758–61.
Fahndrich M, Sandmann M. Endoscopic full-thickness resection for gastrointestinal lesions using the over-the-scope clip system: a case series. Endoscopy. 2015;47(1):76–9.
Al-Bawardy B, Rajan E, Wong Kee Song LM. Over-the-scope clip-assisted endoscopic full-thickness resection of epithelial and subepithelial GI lesions. Gastrointest Endosc. 2017;85(5):1087–92.
Schmidt A, Beyna T, Schumacher B, Meining A, Richter-Schrag HJ, Messmann H, et al. Colonoscopic full-thickness resection using an over-the-scope device: a prospective multicentre study in various indications. Gut. 2018;67(7):1280-9.
Vitali F, Naegel A, Siebler J, Neurath MF, Rath T. Endoscopic full-thickness resection with an over-the-scope clip device (FTRD) in the colorectum: results from a university tertiary referral center. Endosc Int Open. 2018;6(1):E98–e103.
Richter-Schrag HJ, Walker C, Thimme R, Fischer A. Full thickness resection device (FTRD). Experience and outcome for benign neoplasms of the rectum and colon. Chirurg. 2016;87(4):316–25.
Valli PV, Mertens J, Bauerfeind P. Safe and successful resection of difficult GI lesions using a novel single-step full-thickness resection device (FTRD(R)). Surg Endosc. 2018;32(1):289-99.
Andrisani G, Soriani P, Manno M, Pizzicannella M, Pugliese F, Mutignani M, et al. Colo-rectal endoscopic full-thickness resection (EFTR) with the over-the-scope device (FTRD((R))): a multicenter Italian experience. Dig Liver Dis. 2019;51(3):375–81.
Hayashi N, Tanaka S, Hewett DG, Kaltenbach TR, Sano Y, Ponchon T, et al. Endoscopic prediction of deep submucosal invasive carcinoma: validation of the narrow-band imaging international colorectal endoscopic (NICE) classification. Gastrointest Endosc. 2013;78(4):625–32.
Berr F, Wagner A, Kiesslich T, Friesenbichler P, Neureiter D. Untutored learning curve to establish endoscopic submucosal dissection on competence level. Digestion. 2014;89(3):184–93.
No funding received for the presented study.
Ethics approval and consent to participate
The study has been performed in accordance with the Declaration of Helsinki and has been approved by Institutional Board Review of the Gemeinschaftskrankenhaus Bonn.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
von Helden, A., Hildenbrand, R., Sido, B. et al. Endoscopic full-thickness resection using an over-the-scope device for treatment of recurrent / residual colorectal neoplasia: a single-center case series. BMC Gastroenterol 19, 121 (2019). https://doi.org/10.1186/s12876-019-1043-8